• Long-term outcome in IPAH with Tracleer first-line treatment (figure 13)³⁸

Figure 13: Kaplan Meier survival estimates in patients treated with Tracleer first-line compared to predicted survival using the d’Alonzo equation (NIH)³⁸

• Long-term outcome in PAH-SSc patients treated with Tracleer first-line treatment (figure 14)³⁹

Figure 14: Kaplan-Meier survival estimates in patients treated with first-line Tracleer indirectly compared to a matched historical control group³⁹

• Long-term outcome in Class III IPAH patients treated with first-line Tracleer therapy indirectly compared with first-line epoprostenol therapy (figure 15)⁴⁰

Figure 15: Kaplan-Meier survival estimates for matched historical cohorts of patients treated with first-line Tracleer or first-line epoprostenol⁴⁰